Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL) Each Administered with a Background Regimen in HIV-1
Greenberg, Richard
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
11/1/08
→
10/31/12
Funding
Gilead Sciences Inc:
$6,590.00
View all
View less